Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
GermanyStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
GermanyStudy on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults
GermanyStudy on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis
GermanyStudy of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
GermanyStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
GermanyStudy on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma
GermanyStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
GermanyStudy of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
GermanyStudy on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
